Zusammenfassung
Pharma-Marketing beginnt früh in der medizinischen Ausbildung. In diesem Kapitel werden die Art und Häufigkeit von Interaktionen zwischen angehenden Medizinern und pharmazeutischen Unternehmen (pU) beschrieben. Darüber hinaus werden Daten zu Richtlinien und Lehrveranstaltungen, die den Einfluss der pU auf die angehenden Mediziner reduzieren sollen, präsentiert.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
AMSA Scorecard (2017) http://amsascorecard.org/. Zugegriffen: 16. Febr. 2018
Austad KE, Avorn J, Kesselheim AS (2011) Medical students’ exposure to and attitudes about the pharmaceutical industry: A systematic review. PLoS Medicine 8:e1001037
Austad KE, Avorn J, Jm F et al (2013) Changing interactions between physician trainees and the pharmaceutical industry: A national survey. Journal of General Internal Medicine 28:1064–1071
Austad KE, Avorn J, Franklin JM et al (2014) Association of marketing interactions with medical trainees’ knowledge about evidence-based prescribing: Results from a national survey. JAMA Internal Medicine 174:1283–1290
Bellin M, McCarthy S, Drevlow L, Pierach C (2004) Medical students’ exposure to pharmaceutical industry marketing: A survey at one U.S. medical school. Academic Medicine 79:1041–1045
Brown SR, Evans DV, Fugh-Berman A (2015) Pharmaceutical industry interactions in family medicine residencies decreased between 2008 and 2013. Family Medicine 47:279–282
Campbell EG, Rao SR, DesRoches CM et al (2010) Physician professionalism and changes in physician-industry relationships from 2004 to 2009. Archives of Internal Medicine 170:1820–1826
Epstein AJ, Asch DA, Barry CL (2013) Effects of conflict-of-interest policies in psychiatry residency on antidepressant prescribing. Leonard Davis Institute of Health Economics Issue Briefs 18:1–4
Etain B, Guittet L, Weiss N et al (2014) Attitudes of medical students towards conflict of interest: A national survey in France. PLoS One 9:e92858
Fitz MM, Homan D, Reddy S et al (2007) The hidden curriculum: Medical students’ changing opinions toward the pharmaceutical industry. Academic Medicine 82:S1–S3
Fleischman W, Agrawal S, King M et al (2016) Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: Cross sectional ecological study. British Medical Journal 354:i4189
Grande D, Frosch DL, Perkins AW, Kahn BE (2009) Effect of exposure to small pharmaceutical promotional items on treatment preferences. Archives of Internal Medicine 169:887–893
Huang FY, Weiss DS, Fenimore PG et al (2005) The association of pharmaceutical company promotional spending with resident physician prescribing behavior. Academic Psychiatry 29:500–501
Jahnke K, Kremer MS, Schmidt CO et al (2014) German medical students’ exposure and attitudes toward pharmaceutical promotion: A cross-sectional survey. GMS Zeitschrift für Medizinische Ausbildung 31:Doc32
Kim A, Mumm LA, Korenstein D (2012) Routine conflict of interest disclosure by preclinical lecturers and medical students’ attitudes toward the pharmaceutical and device industries. Journal of the American Medical Association 308:2187–2189
King M, Essick C, Bearman P, Ross JS (2013) Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis. BMJ 346:f264
Lea D, Spigset O, Slordal L (2010) Norwegian medical students’ attitudes towards the pharmaceutical industry. European Journal of Clinical Pharmacology 66:727–733
Lieb K, Koch C (2013) Medical students’ attitudes to and contact with the pharmaceutical industry: A survey at eight German university hospitals. Deutsches Ärzteblatt International 110:584–590
Lieb K, Koch C (2014) Conflicts of interest in medical school: Missing policies and high need for student information at most German universities. GMS Zeitschrift für Medizinische Ausbildung 31:Doc10
Lieb K, Scheurich A (2014) Contact between doctors and the pharmaceutical industry, their perceptions, and the effects on prescribing habits. PLoS One 9:e110130
Loertscher LL, Halvorsen AJ, Beasley BW et al (2010) Pharmaceutical industry support and residency education: A survey of internal medicine program directors. Archives of Internal Medicine 170:356–362
Monaghan MS, Galt KA, Turner PD et al (2003) Student understanding of the relationship between the health professions and the pharmaceutical industry. Teaching and Learning in Medicine 15:14–20
Montastruc F, Moulis G, Palmaro A et al (2014) Interactions between medical residents and drug companies: A national survey after the Mediator® affair. PLoS One 9:e104828
Nakayama DK, Bozeman AP (2009) Industry support of graduate medical education in surgery. Am Surg 75:395–400
Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN (2004) The ethics of pharmaceutical industry relationships with medical students. Med J Aust 180:411–414
Sandberg WS, Carlos R, Sandberg EH, Roizen MF (1997) The effect of educational gifts from pharmaceutical firms on medical students’ recall of company names or products. Acad Med 72:916–918
Sarikaya O, Civaner M, Vatansever K (2009) Exposure of medical students to pharmaceutical marketing in primary care settings: Frequent and influential. Advances in Health Sciences Education: Theory and Practice 14:713–724
Schneider JA, Arora V, Kasza K et al (2006) Residents’ perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention. Academic Medicine 81:595–602
Schwartz TL, Kuhles DJ, Wade M, Masand PS (2001) Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits. Annals of Clinical Psychiatry 13:159–162
Sierles FS, Brodkey AC, Cleary LM et al (2005) Medical students’ exposure to and attitudes about drug company interactions: A national survey. Journal of the American Medical Association 294:1034–1042
Sierles FS, Kessler KH, Mintz M et al (2015) Changes in medical students’ exposure to and attitudes about drug company interactions from 2003 to 2012: A multi-institutional follow-up survey. Academic Medicine 90:1137–1146
Soyk C, Pfefferkorn B, McBride P, Rieselbach R (2010) Medical student exposure to and attitudes about pharmaceutical companies. Wisconsin Medical Journal 109:142–148
Spingarn RW, Berlin JA, Strom BL (1996) When pharmaceutical manufacturers’ employees present grand rounds, what do residents remember? Academic Medicine 71:86–88
Spurling GK, Mansfield PR, Montgomery BD et al (2010) Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: A systematic review. PLoS Medicine 7:e1000352
Steinman MA, Shlipak MG, McPhee SJ (2001) Of principles and pens: Attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. American Journal of Medicine 110:551–557
Vuorenkoski L, Valta M, Helve O (2008) Effect of legislative changes in drug promotion on medical students: Questionnaire survey. Medical Education 42:1172–1177
Wang Y, Adelman RA (2009) A study of interactions between pharmaceutical representatives and ophthalmology trainees. American Journal of Ophthalmology 148:619–622.e3
Wazana A (2000) Physicians and the pharmaceutical industry: Is a gift ever just a gift? Journal of the American Medical Association 283:373–380
Weißkircher J, Koch C, Dreimüller N, Lieb K (2017) Conflicts of interest in medicine. A systematic review of published and scientifically evaluated curricula. GMS Journal for Medical Education 34:Doc37
Wilkes MS, Hoffman JR (2001) An innovative approach to educating medical students about pharmaceutical promotion. Academic Medicine 76:1271–1277
Yeh JS, Austad KE, Franklin JM et al (2015) Medical schools’ industry interaction policies not associated with trainees’ self-reported behavior as residents: Results of a national survey. Journal of Graduate Medical Education 7:595–602
Yeh JS, Franklin JM, Avorn J et al (2016) Association of industry payments to physicians with the prescribing of brand-name statins in Massachusetts. JAMA Internal Medicine 176:763–768
Zipkin DA, Steinman MA (2005) Interactions between pharmaceutical representatives and doctors in training: A thematic review. Journal of General Internal Medicine 20:777–786
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Koch, C., Lieb, K. (2019). Medizinische Ausbildung und Pharmamarketing. In: Kölbel, R. (eds) Institutionelle Korruption und Arzneimittelvertrieb. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57416-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-57416-4_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-57415-7
Online ISBN: 978-3-662-57416-4
eBook Packages: Social Science and Law (German Language)